v3.26.1
Condensed Balance Sheet - USD ($)
Jun. 30, 2026
Feb. 25, 2026
Dec. 31, 2025
Dec. 31, 2024
Current assets        
Cash $ 832,812      
Prepaid expenses 128,649      
Total current assets 961,461      
Noncurrent assets        
Long-term prepaid expenses 107,208      
Marketable securities held in Trust Account 75,238,468      
Deferred offering costs   $ 128,033    
Total Assets 76,307,137 128,033    
Current liabilities:        
Accounts payable 15,353      
Accrued offering costs   128,033    
Accrued expenses 40,234 8,697    
Total Current Liabilities 55,587 136,730    
Deferred underwriting fee payable 2,250,000      
Total liabilities 2,305,587      
Commitments and Contingencies    
Class A ordinary shares subject to possible redemption, 7,500,000 shares at a redemption value of $10.00 per share 75,238,468      
Shareholders' Deficit        
Preference shares, $0.0001 par value, 1,000,000 shares authorized; none issued and outstanding 0 0    
Additional paid-in-capital 0 24,868    
Accumulated deficit (1,237,078) (33,697)    
Total Shareholders' Deficit (1,236,918) (8,697)    
TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT 76,307,137 128,033    
Common Class A [Member]        
Current liabilities:        
Class A ordinary shares subject to possible redemption, 7,500,000 shares at a redemption value of $10.00 per share 75,238,468      
Shareholders' Deficit        
Common Stock, Value, Issued 28 0    
Common Class B [Member]        
Shareholders' Deficit        
Common Stock, Value, Issued 132 $ 132    
OHB Pediatrics Ltd [Member]        
Current assets        
Cash 26,982,000   $ 0  
Prepaid clinical trial costs 1,591,000   1,228,000 $ 14,000
Prepaid taxes 413,000   226,000 0
Total current assets 28,986,000   1,454,000 14,000
Noncurrent assets        
Deposits 3,006,000   43,000 0
Deferred offering costs 691,000   0  
Total noncurrent assets 3,697,000   43,000  
Total Assets 32,683,000   1,497,000 14,000
Current liabilities:        
Accounts payable 2,501,000   168,000 117,000
Accounts payable and accrued expenses 7,030,000   1,528,000 230,000
Due to parent Co. 7,301,000   0 141,000
Total Current Liabilities 14,331,000   1,528,000 371,000
Total liabilities 14,331,000   1,528,000 371,000
Commitments and Contingencies    
Mezzanine equity        
Series A redeemable convertible preferred stock, $0.000001 par value; 32,500,000 and none authorized, issued and outstanding as of June 30, 2026 and December 31, 2025 respectively 31,890,000   0  
Shareholders' Deficit        
Common Stock, Value, Issued 0   0 0
Additional paid-in-capital 15,976,000   15,976,000 0
Accumulated deficit (29,514,000)   (16,007,000) (357,000)
Total Shareholders' Deficit (13,538,000)   (31,000) (357,000)
TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT $ 32,683,000   $ 1,497,000 $ 14,000